Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care

CompletedOBSERVATIONAL
Enrollment

252

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
Trial Locations (43)

105203

Site Ref # / Investigator 50723, Moscow

105229

Site Ref # / Investigator 50725, Moscow

109451

Site Ref # / Investigator 50742, Moscow

Site Ref # / Investigator 50743, Moscow

115682

Site Ref # / Investigator 50724, Moscow

121356

Site Ref # / Investigator 50739, Moscow

123060

Site Ref # / Investigator 50732, Moscow

123098

Site Ref # / Investigator 50738, Moscow

123308

Site Ref # / Investigator 50744, Moscow

125009

Site Reference ID/Investigator# 28989, Moscow

Site Reference ID/Investigator# 28990, Moscow

Site Reference ID/Investigator# 29195, Moscow

Site Reference ID/Investigator# 29482, Moscow

Site Reference ID/Investigator# 29483, Moscow

127206

Site Ref # / Investigator 50740, Moscow

127473

Site Ref # / Investigator 50733, Moscow

127543

Site Ref # / Investigator 50745, Moscow

127642

Site Ref # / Investigator 50741, Moscow

143420

Site Ref # / Investigator 50736, Krasnogorsk

160001

Site Ref # / Investigator 50730, Vologda

173008

Site Ref # / Investigator 50734, V. Novgorod

190000

Site Reference ID/Investigator# 28957, Saint Petersburg

Site Reference ID/Investigator# 28997, Saint Petersburg

Site Reference ID/Investigator# 28999, Saint Petersburg

Site Reference ID/Investigator# 29001, Saint Petersburg

191015

Site Reference ID/Investigator# 32403, Saint Petersburg

236000

Site Reference ID/Investigator# 29084, Kaliningrad

300036

Site Reference ID/Investigator# 32404, Tula

308007

Site Ref # / Investigator 50728, Belgorod

308036

Site Ref # / Investigator 50727, Lipetsk

394024

Site Ref # / Investigator 50735, Voronezh

394082

Site Ref # / Investigator 50726, Voronezh

426009

Site Ref # / Investigator 50731, Izhevsk

432000

Site Reference ID/Investigator# 29095, Ulyanovsk

454047

Site Ref # / Investigator 50737, Chelyabinsk

614014

Site Reference ID/Investigator# 28968, Perm

Site Reference ID/Investigator# 28969, Perm

620000

Site Reference ID/Investigator# 6002, Yekaterinburg

626200

Site Reference ID/Investigator# 29163, Khanty-Mansiysk

628400

Site Reference ID/Investigator# 29008, Surgut

628600

Site Ref # / Investigator 50746, Khanty-Mansiysk

Site Reference ID/Investigator# 28956, Nizhnevartovsk

629001

Site Ref # / Investigator 50729, Salekhard

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Scientific Research Institute of Rheumatology, Moscow

UNKNOWN

collaborator

Almedis

INDUSTRY

lead

Abbott

INDUSTRY